| Structure | Chemical Name | CAS | MF |
|
3-Benzofuranamine,2,3-dihydro-4,6-dimethoxy-(9CI)
|
756801-05-5
|
C10H13NO3
|
|
N-(2-phenylethyl)piperidine-2-carboxamide
|
756801-21-5
|
C14H20N2O
|
|
3-Isoquinolinecarboxylicacid,7-amino-1,2,3,4-tetrahydro-(9CI)
|
756803-94-8
|
C10H12N2O2
|
|
4-Pyridinethiol,1-butyl-1,4-dihydro-(9CI)
|
756804-90-7
|
C9H15NS
|
|
2-Pyridinemethanamine,3-fluoro-4-methyl-(9CI)
|
756807-57-5
|
C7H9FN2
|
|
3,3'-bipyridin-5-aMine
|
756809-59-3
|
C10H9N3
|
|
4-Isoquinolineaceticacid,6-ethyl-(9CI)
|
756809-77-5
|
C13H13NO2
|
|
1,3,5-Triazin-2(1H)-one,5-ethyl-5,6-dihydro-(9CI)
|
756810-44-3
|
C5H9N3O
|
|
Hydroxylamine, O-[1-(4-fluorophenyl)-2-propynyl]- (9CI)
|
756813-46-4
|
C9H8FNO
|
|
2-[(2,4-Dichlorobenzoyl)amino]-5-(2-pyrimidinyloxy)-benzoic acid hydrate
|
756813-87-3
|
C18H11Cl2N3O4
|
|
Methyl 2-(4-amino-3-iodophenyl)-2-methylpropanoate
|
756813-88-4
|
C11H14INO2
|
|
3-Pentanamine, 3-(trifluoromethyl)-
|
756814-11-6
|
C6H12F3N
|
|
(R)-3-(2-NITROPHENYL)-BETA-ALANINE
|
756814-14-9
|
C9H10N2O4
|
|
2-Piperidinecarboxylicacid,4-ethyl-,(2R,4R)-rel-(9CI)
|
756814-90-1
|
C8H15NO2
|
|
1H-Pyrazol-3-amine,5-(4-morpholinyl)-(9CI)
|
756814-98-9
|
C7H12N4O
|
|
1,4-Thiazepane-1,1-dioxide trifluoroacetate
|
756815-81-3
|
C5H11NO2S
|
|
Boronic acid, [2-(dimethylamino)-5-pyrimidinyl]- (9CI)
|
756817-82-0
|
C6H10BN3O2
|
|
2-(2-AMINO-ETHYL)-ADAMANTAN-2-OL
|
756818-48-1
|
C12H21NO
|
|
3-Pyrrolidineacetic acid ethyl ester
|
756818-49-2
|
C8H15NO2
|
|
(R)-6-methylchroman-4-amine
|
756818-55-0
|
C10H13NO
|
|
2,3,4-Piperidinetrione,3-oxime,(3Z)-(9CI)
|
756818-62-9
|
C5H6N2O3
|
|
Siloxanes and silicones, di-Me, mono[3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl] group-terminated polymers with Bu methacrylate, 2-ethylhexyl acrylate and Me methacrylate
|
756819-45-1
|
|
|
4H-1,2,4-Triazole,3-methyl-4-(2-propenyl)-(9CI)
|
756819-66-6
|
C6H9N3
|
|
4H-1,2,4-Triazole,3-methyl-4-(2-propynyl)-(9CI)
|
756819-67-7
|
C6H7N3
|
|
4H-1,2,4-Triazole,4-cyclohexyl-3-methyl-(9CI)
|
756819-68-8
|
C9H15N3
|
|
Acetic acid, [(dimethylamino)methylene]hydrazide (9CI)
|
756819-70-2
|
C5H11N3O
|
|
1-(3-chloropropyl)-5-methoxy-1H-indole
|
756820-10-7
|
C12H14ClNO
|
|
1H-Indole,2,3-dihydro-5-methoxy-1-(2-propynyl)-(9CI)
|
756820-13-0
|
C12H13NO
|
|
N-(2-azidoacetyl)-Neuraminicacid
|
756823-87-7
|
C11H18N4O9
|
|
1,1'-Bis[bis(5-Methyl-2-furanyl) phosphino]ferrocene, 98% HiersoPHOS-3
|
756824-22-3
|
C30H28FeO4P210*
|
|
4'-Hydroxy AzithroMycin
|
756825-20-4
|
C38H72N2O13
|
|
6H-1,3-Oxazin-6-one, 2-ethenyl-4-hydroxy-5-methyl- (9CI)
|
756826-43-4
|
C7H7NO3
|
|
Cyclopropanecarboxamide, N-hydroxy-2,2,3,3-tetramethyl- (9CI)
|
756830-94-1
|
C8H15NO2
|
|
Cyclopropanecarboxylic acid, 2,2,3,3-tetramethyl-, hydrazide (9CI)
|
756830-97-4
|
C8H16N2O
|
|
Carbamic acid, [(2R,3R)-2-hydroxy-3-methyl-4-pentenyl]-, 1,1-dimethylethyl
|
756834-76-1
|
C11H21NO3
|
|
1H-Indazol-5-ol, 1-methyl- (9CI)
|
756839-14-2
|
C8H8N2O
|
|
TERT-BUTYL 2-AMINO-5-FLUOROBENZYLCARBAMATE
|
756839-26-6
|
C12H17FN2O2
|
|
5-METHOXY-1-METHYLINDAZOLE
|
756839-44-8
|
C9H10N2O
|
|
Benzonitrile, 3,4-diethoxy-2-fluoro- (9CI)
|
756840-04-7
|
C11H12FNO2
|
|
Benzenemethanamine, N-ethylidene-4-methoxy- (9CI)
|
756845-56-4
|
C10H13NO
|
|
Cyclopropanamine, N-(cyclohexylmethylene)- (9CI)
|
756845-63-3
|
C10H17N
|
|
Cyclopropanamine, N-[(4-methoxyphenyl)methylene]- (9CI)
|
756845-65-5
|
C11H13NO
|
|
Cyclopropanamine, N-[(4-fluorophenyl)methylene]- (9CI)
|
756845-67-7
|
C10H10FN
|
|
3-Thiophenecarboxamide, 2-[(2-[1,1'-biphenyl]-4-ylacetyl)amino]-
|
756849-36-2
|
C19H16N2O2S
|
|
3-Pyridazinecarboxamide,N-(2,3-dihydro-1H-inden-5-yl)-1,4,5,6-tetrahydro-6-
|
756849-84-0
|
C14H15N3O2
|
|
Acetamide, N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(thieno[2,3-d]pyrimidin-4-yloxy)-
|
756857-71-3
|
C16H13N3O4S
|
|
[2-(3,4-DIMETHOXY-PHENYL)-THIAZOL-4-YL]-ACETIC ACID
|
756858-99-8
|
C13H13NO4S
|
|
(2E)-3-[2-[ACETYL(PHENYL)AMINO]-1,3-THIAZOL-4-YL]ACRYLIC ACID
|
756859-00-4
|
C14H12N2O3S
|
|
1-[[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL]PIPERAZINE
|
756859-05-9
|
C11H13F3N2O3S
|
|
3-Benzofuranacetamide, 6-methoxy-N-2-thiazolyl-
|
756865-45-9
|
C14H12N2O3S
|
|
2-Propenamide, N-cycloheptyl-3-[4-methoxy-3-(4-morpholinylsulfonyl)phenyl]-
|
756865-61-9
|
C21H30N2O5S
|
|
(2ALPHA,3BETA,4ALPHA)-URS-12-ENE-2,3,23,28-TETROL
|
756865-68-6
|
C30H50O4
|
|
3-Pyridazinecarboxamide,N-(2-ethylphenyl)-1,4,5,6-tetrahydro-6-oxo-(9CI)
|
756866-93-0
|
C13H15N3O2
|
|
2-(2-Morpholin-4-yl-ethylamino)-5-nitro-benzonitrile
|
756869-15-5
|
C13H16N4O3
|
|
Bromodimethylbiphenyl
|
756873-19-5
|
C14H13Br
|
|
Pentanoic acid, 5-[(methoxycarbonyl)methylamino]-
|
756874-12-1
|
C8H15NO4
|
|
[2-(N-Boc-N-methyl-amino)-ethoxy]-acetic acid
|
756874-17-6
|
C10H19NO5
|
|
Pentanoic acid, 4-(dimethylamino)- (9CI)
|
756874-19-8
|
C7H15NO2
|
|
K6PC-5
|
756875-51-1
|
C19H37NO4
|
|
1-CHLORO-4-ETHYNYL-2-FLUORO-BENZENE
|
756895-72-4
|
C8H4ClF
|
|
1,2-Benzenediol, 3-(2-pyridinylmethyl)- (9CI)
|
756900-93-3
|
C12H11NO2
|
|
4-Piperidinone, 1-(2,3-dihydroxyphenyl)- (9CI)
|
756900-94-4
|
C11H13NO3
|
|
Carbamic acid, (2,3-dihydroxyphenyl)-, 1,1-dimethylethyl ester (9CI)
|
756900-97-7
|
C11H15NO4
|
|
1,2-Benzenediol, 3-(1-aminoethyl)- (9CI)
|
756901-00-5
|
C8H11NO2
|
|
6-(4-methylpiperidin-1-yl)pyridazin-3-ol
|
756901-36-7
|
C10H15N3O
|
|
3-chloro-6-(4-methyl-1-piperidinyl)pyridazine
|
756901-46-9
|
C10H14ClN3
|
|
1,2,4-Metheno-1H-cyclobuta[cd]pentalen-3-amine,octahydro-(9CI)
|
757124-25-7
|
C10H13N
|
|
Benzenemethanol, -alpha--(1-aminoethyl)-, radical ion(1+) (9CI)
|
757124-50-8
|
C9H13NO
|
|
3,3,4,4,5,5,6,6,6-Nonafluorohexane-1-sulphonic acid
|
757124-72-4
|
C6H5F9O3S
|
|
Hydrazine, (2-methyl-5-benzofuranyl)-
|
757126-27-5
|
C9H10N2O
|
|
4-Piperidinecarboxylic acid, 4-hydroxy-1-methyl- (9CI)
|
757127-21-2
|
C7H13NO3
|
|
1,2-Naphthalenediol, 7-(dimethylamino)-5,6,7,8-tetrahydro- (9CI)
|
757129-89-8
|
C12H17NO2
|
|
Benzenepropanol, beta-amino-3-hydroxy-4-methoxy- (9CI)
|
757130-45-3
|
C10H15NO3
|
|
Benzoxazole, 2-(1-ethyl-1,4,5,6-tetrahydro-2-pyrimidinyl)- (9CI)
|
757131-67-2
|
C13H15N3O
|
|
Pentitol, 1,5-anhydro-2,4-dideoxy-2-(dimethylamino)-, 3-acetate (9CI)
|
757132-30-2
|
C9H17NO3
|
|
7-Methylindan-4-yl 1-Naphthyl Ketimine
DISCONTINUED
|
757133-29-2
|
C21H19N
|
|
2-Butanone,3-methyl-3-[methyl(1-methylethyl)amino]-(9CI)
|
757133-59-8
|
C9H19NO
|
|
MEOSUC-LYS(2-PICOLINOYL)-ALA-PRO-VAL-PNA
|
757139-27-8
|
C36H48N8O10
|
|
4-(Aminomethyl)benzenebutanoic acid ethyl ester
|
757139-57-4
|
C13H19NO2
|
|
Cyclobutanemethanamine, 3-amino-2,2-dimethyl-, cis- (9CI)
|
757139-71-2
|
C7H16N2
|
|
Benzoyl chloride, 3-(2-propenylamino)- (9CI)
|
757140-32-2
|
C10H10ClNO
|
|
2H-Pyrazolo[3,4-b]pyridin-3-ol, 6-methyl- (9CI)
|
757142-59-9
|
C7H7N3O
|
|
1,3-Oxaphosphol-5(2H)-one, 3,3-dihydro-2-(phosphinomethylene)- (9CI)
|
757144-82-4
|
C4H4O2P2
|
|
1H-Imidazol-2-amine,4,5-dihydro-4-phenoxy-(9CI)
|
757145-09-8
|
C9H11N3O
|
|
2-Cyclohexen-1-one, 5-(2-aminoethyl)-3-hydroxy- (9CI)
|
757145-67-8
|
C8H13NO2
|
|
L-Alanine, N-(1-cyanoethyl)- (9CI)
|
757146-61-5
|
C6H10N2O2
|
|
Piperazine, 2,3,5-trimethyl-, (2alpha,3beta,5beta)- (9CI)
|
757147-87-8
|
C7H16N2
|
|
Piperazine, 1-(2-chloro-1-oxobutyl)-4-methyl- (9CI)
|
757149-14-7
|
C9H17ClN2O
|
|
Acetic acid, [4-[(6-hydroxy-4,5,7-trimethyl-2-benzothiazolyl)amino]phenoxy]-, ethyl ester (9CI)
|
757151-39-6
|
C20H22N2O4S
|
|
Glycine, N-(4-hydroxy-3-pyridinyl)- (9CI)
|
757151-41-0
|
C7H8N2O3
|
|
N-[4-(1-aminoethyl)phenyl]acetamide
|
757151-43-2
|
C10H14N2O
|
|
Thieno[2,3-c]pyridine, 4,5,6,7-tetrahydro-2-methyl- (9CI)
|
757152-25-3
|
C8H11NS
|
|
1-(chloromethyl)-4-methyl-1H-pyrazole
|
757152-30-0
|
C5H7ClN2
|
|
Phenol, 4-(2-amino-1-methylethyl)-, (S)- (9CI)
|
757153-78-9
|
C9H13NO
|
|
1H-Benzimidazol-5-ol, 4-amino-2-methyl- (9CI)
|
757153-87-0
|
C8H9N3O
|
|
2-(CHLOROMETHYL)-N-ETHYLANILINE
|
757153-92-7
|
C9H12ClN
|
|
4-(chloromethyl)-2-cyclopropyl-1,3-thiazole
|
757155-82-1
|
C7H8ClNS
|
|
beta-D-Ribopyranose, 4-amino-4-deoxy- (9CI)
|
757156-35-7
|
C5H11NO4
|
|
Cyclopropanecarboxylic acid, 1-amino-2,2,3-trimethyl-, methyl ester, cis- (9CI)
|
757156-85-7
|
C8H15NO2
|
|
Benzeneacetic acid, 2-amino-5-methoxy-alpha-oxo- (9CI)
|
757157-10-1
|
C9H9NO4
|